X4 Pharmaceuticals Inc Share Price

NASDAQ: XFOR

Small Cap

$3.04

-0.17

(-5.14%)

as on September 18, 2025 at 1:29 am IST

$₹

X4 Pharmaceuticals Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's High
$3.04
Day's Price Range
$3.37
$3.04
10.86%
Upside
52 Week's Low
52 Week's High
$1.35
52-Week Price Range
$26.83
$3.04
55.59%
Downside
782.53%
Upside

X4 Pharmaceuticals Inc share price movements today

Previous Close: $3.21
Open: $3.20
Volume: 1.2M
Day's Low - High: $3.04 - $3.37
52 Week Low - High: $1.35 - $26.83

X4 Pharmaceuticals Inc Historical Returns

1 Month Return: + 22.09 %
3 Month Return: + 7.8 %
1 Year Return: -85.59 %
3 Year Return: -90.79 %
5 Year Return: -98.64 %

X4 Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check X4 Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$68.2M

EPS (TTM)

-4.0275

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-104.5M

Revenue (TTM)

32.8M

Profit Margin

0.00%

Return On Equity TTM

0.00%

X4 Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of X4 Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
X4 Pharmaceuticals Inc	BUY	$68.2M	-98.64%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	248.74%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for X4 Pharmaceuticals Inc Stock including INR - Dollar returns

The X4 Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y
5Y

X4 Pharmaceuticals Inc investment value today

Current value as on today

₹19,361

Returns

₹80,639

(-80.64%)

Returns from X4 Pharmaceuticals Inc Stock

₹85,592 (-85.59%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on X4 Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for X4 Pharmaceuticals Inc. Average target price of $19.75

X4 Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on X4 Pharmaceuticals Inc.

What analysts predicted

84.61%UPSIDE

Target Price

$19.75

Current Price

$3.04

Analyzed by

12 Analysts

Target

$19.75

X4 Pharmaceuticals Inc target price $19.75, a slight upside of 84.61% compared to current price of $3.04. According to 12 analysts rating.

X4 Pharmaceuticals Inc Stock's Interest Amongst Investors

Investment in X4 Pharmaceuticals Inc Shares on INDmoney has dropped by -35.18% over the past 30 days, indicating reduced transactional activity.

Time period: August 19, 2025 to September 18, 2025

Change:-35.18% versus previous 30 day period

Search interest for X4 Pharmaceuticals Inc Stock has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-16% versus previous 30 day period

X4 Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	3	-	0	0	1	28	1
Gross Profit	0	0	0	2	0	0	0	1	24	1
Operating Income	-25	-25	-27	-25	-37	71	-34	-35	-9	-26
EBITDA	-22	-54	0	-17	-49	-33	-34	-36	2	-26
Interest Expense	1	1	1	1	1	2	2	2	2	2
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-55	-55	-2	-19	-51	90	-36	-39	0	-25
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-55	-55	-2	-19	-51	90	-36	-39	0	-25
Net Profit Margin	0.00%	0.00%	0.00%	-625.16%	0.00%	16133.75%	-6552.86%	-2776.92%	0.98%	-1304.66%

X4 Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	3	3	3	-	-	-	2
Gross Profit	0	0	3	0	3	-1	-1	-1	1
Operating Income	-24	-36	-45	-51	-59	-85	-87	-107	-36
EBITDA	-20	-31	-45	-51	-59	-84	-87	-107	-27
Interest Expense	2	2	1	2	2	3	3	5	8
Depreciation	-	0	0	0	0	0	0	0	0
Income Before Tax	-22	-33	-43	-52	-61	-88	-93	-101	-37
Income Tax Expense	2	1	3	3	0	0	0	0	0
Net Income	-22	-33	-43	-56	-62	-88	-93	-101	-37
Net Profit Margin	0.00%	0.00%	-1229.17%	-1886.80%	-2071.03%	0.00%	0.00%	0.00%	-1464.61%

X4 Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-55	-2	-19	-51	90	-36	-39	0	-25
Operating Cash Flow	-21	-20	-27	-33	-30	-34	-32	-12	-29
Investing Cash Flow	-4	-5	-4	-5	96	-15	-8	-3	23
Financing Cash Flow	69	21	0	-	20	-	0	-	5
Change in Cash	43	-4	-32	-38	86	-49	-41	-15	-1

X4 Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-22	-33	-43	-52	-62	-88	-93	-101	-37
Operating Cash Flow	-21	-27	-40	-48	-58	-70	-77	-96	-130
Investing Cash Flow	0	0	0	27	-1	0	0	-14	66
Financing Cash Flow	18	101	-4	140	12	74	117	88	20
Change in Cash	-3	73	-45	119	-47	2	39	-22	-43

Global Institutional Holdings in X4 Pharmaceuticals Inc

Funds	Holdings
Rhumbline Advisers	0.09%
SG Americas Securities, LLC	0.04%
T. Rowe Price Associates, Inc.	0.04%
Wealth Enhancement Advisory Services, LLC	0.02%
Ronald Blue Trust, Inc.	0%

See all

Insights on X4 Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 154.0%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 202.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, XFOR stock has moved down by -7.9%

About X4 Pharmaceuticals Inc

x4 pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking and reverse immune suppression, which is fundamental to treating cancer and certain rare, genetic primary immunodeficiency diseases. our oral, small molecule drug candidates inhibit the binding of chemokine cxcl12 to c-x-c receptor type 4 (cxcr4), a receptor-ligand pair that plays an essential role in normal immune surveillance. we are committed to advancing the fields of cancer immunotherapy and genetic immune disorders through innovation and investment in our proprietary clinical and preclinical pipeline. x4’s most advanced product candidate, x4p-001-rd, is in a phase 2/3 study in patients with whim syndrome, a rare genetic, primary immunodeficiency disease. x4p-001-io is currently under investigation in multiple phase 1/2 studies in refractory clear cell renal cell carcinoma (ccrcc) and melanoma. our third program, x4p-002, is in preclinical development and designed specifically for the t

Organisation	X4 Pharmaceuticals Inc
Headquarters	61 North Beacon Street, Boston, MA, United States, 02134
Industry	Biotechnology
CEO	Mr. Mark Baldry M.B.A.
E-voting on shares	Click here to vote

Key Management of X4 Pharmaceuticals Inc

Name	Title
Mr. John P. Volpone	President
Dr. Richard Peters M.D., Ph.D.	Founder
Dr. Mary DiBiase Ph.D.	Chief Operating Officer
Ms. Natasha Thoren Esq.	Chief Legal & Compliance Officer
Dr. Christophe Arbet-Engels M.B.A., M.D., Ph.D.	Chief Medical Officer
Mr. Mark Baldry M.B.A.	Chief Commercial Officer
Dr. Adam R. Craig M.B.A., M.D., Ph.D.	Executive Chair
Dr. Renato T. Skerlj Ph.D.	Founder
Dr. Keith T. Flaherty M.D.	Founder & Member of Corporate Advisory Board
Mr. David H. Kirske	Chief Financial Officer

FAQs

What is X4 Pharmaceuticals Inc share price today?

X4 Pharmaceuticals Inc share price today is $3.04 as on September 18, 2025 at 1:29 am IST at the close of the market. X4 Pharmaceuticals Inc share today touched a day high of $3.37 and a low of $3.04.

What is the 52 week high and 52 week low for X4 Pharmaceuticals Inc share?

X4 Pharmaceuticals Inc share touched a 52 week high of $26.83 on December 31, 2024 and a 52 week low of $1.35 on August 11, 2025. X4 Pharmaceuticals Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $3.04,which is 88.67% down from its 52 week high and 125.19% up from its 52 week low.

What is X4 Pharmaceuticals Inc's market capitalisation today?

X4 Pharmaceuticals Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in X4 Pharmaceuticals Inc Stock (XFOR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for X4 Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in X4 Pharmaceuticals Inc Shares that will get you 0.4934 shares as per X4 Pharmaceuticals Inc share price of $3.04 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy X4 Pharmaceuticals Inc Stock (XFOR) from India?

Indian investors can start investing in X4 Pharmaceuticals Inc (XFOR) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 5:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in X4 Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 5:38 pm IST). Based on X4 Pharmaceuticals Inc share’s latest price of $3.04 as on September 18, 2025 at 1:29 am IST, you will get 3.2895 shares of X4 Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that X4 Pharmaceuticals Inc has given to Indian investors in the last 5 years?

X4 Pharmaceuticals Inc stock has given -98.64% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?